臺大學術典藏 |
1989-02 |
FINAL FOCUSING AND ENHANCED DISRUPTION FROM AN UNDERDENSE PLASMA LENS IN A LINEAR COLLIDER.
|
Chen, Pisin; Rajagopalan, S.; Rosenzweig, J.B.; Chen, Pisin; Rajagopalan, S.; Rosenzweig, J.B. |
國立臺灣大學 |
1989-02 |
FINAL FOCUSING AND ENHANCED DISRUPTION FROM AN UNDERDENSE PLASMA LENS IN A LINEAR COLLIDER.
|
Chen, Pisin; Rajagopalan, S.; Rosenzweig, J.B. |
臺大學術典藏 |
2018-09-10T03:25:35Z |
Final iterations in interior point methods - Preconditioned conjugate gradients and modified search directions
|
Wang, W.; WEICHUNG WANG |
國立臺灣大學 |
2000-01 |
Final iterations in interior point methods--preconditioned conjugate gradients and modified search directions
|
Wang, Weichung |
臺大學術典藏 |
2020 |
Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC
|
Shaw A.T.; Passos V.Q.; Chen Z.; Viraswami-Appanna K.; Spigel D.R.; Scagliotti G.V.; Mok T.; Su W.-C.; Nishio M.; Felip E.; Orlov S.; Park K.; CHONG-JEN YU; Tsai C.-M.; Cobo M.; McKeage M.; Nishio M.;Felip E.;Orlov S.;Park K.;Chong-Jen Yu;Tsai C.-M.;Cobo M.;Mckeage M.;Su W.-C.;Mok T.;Scagliotti G.V.;Spigel D.R.;Viraswami-Appanna K.;Chen Z.;Passos V.Q.;Shaw A.T. |
臺大學術典藏 |
2022-06-27T06:59:45Z |
Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC
|
Nishio M.; Felip E.; Orlov S.; Park K.; CHONG-JEN YU; Tsai C.-M.; Cobo M.; McKeage M.; Su W.-C.; Mok T.; Scagliotti G.V.; Spigel D.R.; Viraswami-Appanna K.; Chen Z.; Passos V.Q.; Shaw A.T. |
國立成功大學 |
2020 |
Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC
|
Nishio, M.;Felip, E.;Orlov, S.;Park, K.;Yu, C.-J.;Tsai, C.-M.;Cobo, M.;McKeage, McKeage M.;Su, W.-C.;Mok, T.;Scagliotti, G.V.;Spigel, D.R.;Viraswami-Appanna, K.;Chen, Z.;Passos, V.Q.;Shaw, A.T. |
國立臺灣大學 |
2010 |
Final Overall Survival Os Results from a Phase Iii, Randomised, Open-Label , First-Line Study of Gefitinib G V Carboplatin/Paclitaxel C/P in Clinically Selected Patients with Advanced Non-Small Cell Lung Cancer Nsclc in Asia Ipass
|
楊志新; YANG, CHIH-HSIN |
國立成功大學 |
2022 |
Final Overall Survival, Safety, and Quality of Life Results From a Phase 2 Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced NSCLC
|
Wu, Y.-L.;Lu, S.;Yang, J.C.-H.;Zhou, J.;Seto, T.;Ahn, M.-J.;Su, W.-C.;Yamamoto, N.;Kim, D.-W.;Paolini, J.;Usari, T.;Iadeluca, L.;Wilner, K.D.;Goto, K. |
國立臺灣大學 |
1983 |
Final Position Control of a Two-Degree-of-Freedom Cable-Driven Manipulator
|
黃漢邦; McClamroch, N. H.; Huang, Han-Pang; McClamroch, N. H. |
中原大學 |
2002-12 |
Final Report of Preliminary Study on Severe Accident Management Strategy for the Fourth Nuclear Power Station
|
J.T. Teng;M.T. Lee;A.H. Lee;Y.S. Wang;Y.G. Huang;W.C. Chen;R.Y. Yuann;H.L. Hu;R.F. Chiang;J.Y. Chang;S.C. Chen |
臺大學術典藏 |
2020-05-04T07:55:44Z |
Final Report of the NTCIR-14 FinNum Task: Challenges and Current Status of Fine-Grained Numeral Understanding in Financial Social Media Data.
|
Chen, Chung-Chi;Huang, Hen-Hsen;Takamura, Hiroya;Chen, Hsin-Hsi; Chen, Chung-Chi; Huang, Hen-Hsen; Takamura, Hiroya; Chen, Hsin-Hsi; HSIN-HSI CHEN |
臺大學術典藏 |
2018-09-10T03:46:06Z |
Final Report on the Advanced Acceleration Techniques Working Group, T8
|
P Sprangle,;P Chen,; P Sprangle,; P Chen,; PISIN CHEN |
國立臺灣大學 |
2008-06 |
Final Results from KTeV Experiment on the Decay KL->pi0gg
|
Abouzaid, E.; Hsiung, Y.B. |
臺大學術典藏 |
2018-09-10T07:01:31Z |
Final Results from the KTeV Experiment on the Decay $K_{L} \\to \\pi^0 \\gamma \\gamma$
|
Abouzaid, E.; YEE HSIUNG |
國家衛生研究院 |
2018-07-17 |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG)
|
Hong, RL;Hsiao, CF;Ting, LL;Ko, JY;Wang, CW;Chang, JTC;Lou, PJ;Wang, HM;Tsai, MH;Lai, SC;Liu, TW |
臺大學術典藏 |
2021-10-25T02:57:11Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; |Hsiao C.F; |Ting L.L; |JENG-YUH KO; |Wang C.W; |Chang J.T.C; |Lou P.J; |Wang H.M; |Tsai M.H; |Lai S.C; |Liu T.W. |
臺大學術典藏 |
2018 |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Liu T.W.; Lai S.C; Tsai M.H; Wang H.M; PEI-JEN LOU; Chang J.T.C; Wang C.W; Ko J.Y; Hong R.L; Hsiao C.F; Ting L.L |
臺大學術典藏 |
2021-04-28T06:58:18Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L.; Hsiao C.F.; Ting L.L.; Ko J.Y.; CHUN-WEI WANG; Chang J.T.C.; Lou P.J.; Wang H.M.; Tsai M.H.; Lai S.C.; Liu T.W. |
臺大學術典藏 |
2021-11-15T07:48:12Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; Hsiao C.F; Ting L.L; JENG-YUH KO; Wang C.W; Chang J.T.C; Lou P.J; Wang H.M; Tsai M.H; Lai S.C; Liu T.W. |
臺大學術典藏 |
2021-11-18T04:57:51Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; Hsiao C.F; Ting L.L; JENG-YUH KO; Wang C.W; Chang J.T.C; Lou P.J; Wang H.M; Tsai M.H; Lai S.C; Liu T.W. |
臺大學術典藏 |
2021-03-09T06:46:02Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Ruey-Long Hong;Hsiao C.F.;Ting L.L.;Ko J.Y.;Wang C.W.;Chang J.T.C.;Lou P.J.;Wang H.M.;Tsai M.H.;Lai S.C.;Liu T.W.; RUEY-LONG HONG; Hsiao C.F.; Ting L.L.; Ko J.Y.; Wang C.W.; Chang J.T.C.; Lou P.J.; Wang H.M.; Tsai M.H.; Lai S.C.; Liu T.W. |
國立臺灣大學 |
2011 |
Final Results of Enable 1, a Phase 3, Multicenter Study of Eltrombopag as an Adjunct for Antiviral Treatment of Hepatitis C Virus-Related Chronic Liver Disease Associated with Thrombocytopenia
|
陳培哲; CHEN, PEI-JER |
國家衛生研究院 |
2016-10 |
Final results of NAPOLI-1: A phase 3 study of nal-IRI (MM-398) +/- 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
|
Chen, LT;Wang-Gillam, A;Li, CP;Bodoky, G;Dean, A;Shan, YS;Jameson, GS;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Hubner, R;Chiu, CF;Schwartsmann, G;Braiteh, F;Belanger, B;Bayever, E;de Jong, F;von Hoff, DD;Siveke, JT |
臺大學術典藏 |
2020-12-02T02:33:14Z |
Final results of the large-scale multinational trial PROFILE 1005: Efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer
|
Blackhall F.; Ross Camidge D.; Shaw A.T.; Soria J.-C.; Solomon B.J.; Mok T.; Hirsh V.; J?Nne P.A.; Shi Y.; Pan-Chyr Yang; De Pas T.; Hida T.; De Castro Carpe?O J.; Lanzalone S.; Polli A.; Iyer S.; Reisman A.; Wilner K.D.; Kim D.-W.; Blackhall F.; PAN-CHYR YANG et al. |